MedTrace Logo

Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status

NCT01629940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2012-12-18

No results posted yet for this study

Summary

The investigators propose to obtain facial photographs for use in testing a computer algorithm that recognizes males at high risk for Hypohidrotic Ectodermal Dysplasia (XLHED). FDNA (www.fdna.com), a software company with expertise in the area of facial recognition, is collaborating with the Sponsor in algorithm development based on 2D photographs not requiring special photographic technologies. A frontal facial photograph will be taken at the time of study conduct. The anonymized photographs will be transmitted to FDNA for analysis. A limited number of unaffected controls will be also be recruited.

A subset of affected males between ages 5 and 25 years will have the option of having a blood draw for a set of laboratory studies assessing nutritional status.

Conditions

  • X-linked Hypohidrotic Ectodermal Dysplasia
  • Hypohidrotic Ectodermal Dysplasia

Sponsors & Collaborators

  • Edimer Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Dorothy K Grange, MD · Washington University School of Medicine

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-07-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01629940 on ClinicalTrials.gov